Art

J-GLOBAL ID：200902212643546336   Reference number：04A0753131

Oral alendronate treatment for polyostotic fibrous dysplasia: a case report

多骨性線維性骨形成異常の経口アレンドロナート治療 症例報告

Author (3)： KITAGAWA Y (Nippon Medical School, Tokyo, JPN) ,  TAMAI K (Nippon Medical School, Tokyo, JPN) ,  ITO H (Nippon Medical School, Tokyo, JPN)
Material： Journal of Orthopaedic Science  (J Orthop Sci)
Volume： 9  Issue： 5  Page： 521-525  Publication year： 2004 
JST Material Number： L3245A  ISSN： 0949-2658  CODEN： JOSCFS  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： *Fibrous Dysplasia of Bone ,...
Semi thesaurus term： 骨ターンオーバー

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0753131&from=J-GLOBAL&jstjournalNo=L3245A") }}

JST classification (2)： Clinical application of other drugs acting on metabolism  (GW13070T) ,  Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Substance index (1)： Alendronate

Reference (23)：

• BELL, NH. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. J Clin Endocrinol Metab. 1970, 31, 283-290
• CHAPURLAT, RD. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997, 12, 1746-1752
• DAHLIN, DC. Bone tumors : general aspects and data on 8,542 cases. 1986, 413-420
• DEVOGELAER, JP. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Curr Opin Rheumatol. 2000, 12, 331-335
• ISAIA, GC. Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia. Calcif Tissue Int. 2002, 71, 121-128

Terms in the title (4)： 多骨性線維性骨形成異常 ,  アレンドロナート ,  治療 ,  症例報告